Columbia Research Enhanced Core ETF
RECS
5 hedge funds and large institutions have $22.2M invested in Columbia Research Enhanced Core ETF in 2021 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and closing their positions.
67% more funds holding
Funds holding: 3 → 5 (+2)
0% more capital invested
Capital invested by funds: $22.1M → $22.2M (+$37K)
13.64% less ownership
Funds ownership: 97.47% → 83.83% (-14%)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$298K |
| 2 |
FEM
Fulcrum Equity Management
Plano,
Texas
|
+$278K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
+$20.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
-$755K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$15.4K |
RECS Hedge Fund Activity: Q3 2021 in Review
5 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Columbia Research Enhanced Core ETF (RECS) for Q3 2021, worth a combined $22.2M — up 0.17% from $22.1M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new RECS positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Jane Street, adding an estimated $298K. The largest seller was Ameriprise, cutting an estimated $755K.
- 5 institutional investors held Columbia Research Enhanced Core ETF (RECS) as of Q3 2021, up from 3 in Q2 2021.
- Funds reported $22.2M of Columbia Research Enhanced Core ETF stock for Q3 2021, up 0.17% quarter-over-quarter.
- 2 funds opened new Columbia Research Enhanced Core ETF positions in Q3 2021 and 0 closed out, a net change of +2 holders.
- The largest Columbia Research Enhanced Core ETF buyer in Q3 2021 was Jane Street, an estimated $298K added.
- The largest Columbia Research Enhanced Core ETF seller in Q3 2021 was Ameriprise, an estimated $755K sold.
Based on aggregated 13F filings for Q3 2021.